June 2020 • PharmaTimes Magazine • 4-5
15.
Chain reaction
As the NHS battles coronavirus, the pharma industry is rising to the challenge of managing, sustaining and boosting international supply chains. John Pinching reports
Meet some of pharma and healthcare's promising young leaders brightening the sector's future
Philipp Pointner looks at the rise of telehealth and how this has opened up new targets for fraud
Oxfordshire has a unique life sciences ecosystem which has enabled it to mobilise rapidly and lead the international response to COVID-19, says Sebastian Johnson
Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the Long Term Plan while putting others in jeopardy
30.
In greener shoes
Rich Quelch considers whether pharma is ready for the effects of the climate crisis on global health?
Ana Nicholls on the sharp drop in care for non-COVID patients during the pandemic
PharmaTimes talks to Patient Partnership Index judges Jill Pearcy, director of ABPI Code Engagement, and Richard Davidson, chief executive of Sarcoma UK, about the importance of this initiative and its potential impact
40.
Appointments
Celltrion's Dan Casey on how remote treatment calls for a collaborative approach
A whole new world – despite the earth-shattering turbulence of COVID-19, Andy Hayley from TBWA\WorldHealth believes positive lessons and practices will emerge